dailymailNovember 26, 2018
Tag: BTG , acquisition
The woman who turned BTG into a diverse pharmaceuticals and life sciences company could bank up to £20million from its takeover.
Dame Louise Makin, who took charge in 2004, could net the package in bonuses, shares and performance pay after BTG’s £3.3billion sale to Boston Scientific.
The US firm offered 840p a share, almost 37 per cent more than BTG’s closing price last Monday – the day before the approach – of 615p.
BTG shares have soared 34 per cent since then to 826p on Friday.
-----------------------------------------------------------------------
Editor's Note:
To apply for becoming a contributor of En-CPhI.cn,
welcome to send your CV and sample works to us,
Email: Julia.Zhang@ubmsinoexpo.com.
Contact Us
Tel: (+86) 400 610 1188
WhatsApp/Telegram/Wechat: +86 13621645194
Follow Us: